Location History:
- Ramösa, SE (2012)
- Lund, SE (2016)
- Ramlosa, SE (2017)
Company Filing History:
Years Active: 2012-2017
Title: Maria Allhorn: Innovator in IgE-Mediated Disease Treatment
Introduction
Maria Allhorn is a prominent inventor based in Ramlosa, Sweden. She has made significant contributions to the field of medical science, particularly in the treatment of diseases mediated by IgE antibodies. With a total of 3 patents to her name, Allhorn's work is paving the way for innovative therapeutic approaches.
Latest Patents
Among her latest patents, one notable invention is a treatment for IgE-mediated disease. This invention provides an EndoS polypeptide, or a polynucleotide encoding an EndoS polypeptide, for use in a method for treating or preventing a disease or condition mediated by IgE antibodies. Another significant patent involves an endoglycosidase known as EndoS49, which has specific endoglycosidase activity on native IgG and cleaves a larger variety of Fc glycans than EndoS. This invention also includes methods using EndoS49, deletions thereof, and a mutant that, while lacking endoglycosidase activity, is capable of binding to IgG.
Career Highlights
Maria Allhorn has worked with notable companies such as Genovis AB and Hansa Medical AB. Her experience in these organizations has contributed to her expertise and innovation in the field of biomedicine.
Collaborations
Throughout her career, Allhorn has collaborated with esteemed colleagues, including Mattias Collin and Falk Nimmerjahn. These partnerships have further enhanced her research and development efforts.
Conclusion
Maria Allhorn's contributions to the treatment of IgE-mediated diseases highlight her role as a leading inventor in the medical field. Her innovative patents and collaborations reflect her commitment to advancing healthcare solutions.